![Emil deGoma](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Emil deGoma
Keine laufenden Positionen mehr
Profil
Emil M.
deGoma is currently a Member at Stanford University, American Heart Association, Inc., American College of Cardiology Foundation, and National Lipid Association.
Dr. deGoma is also the Chief Medical Officer at Braveheart Bio, Inc., starting in 2026.
Former positions include Director-Medical Affairs at Cortria Corp., Medical Director & Assistant Professor at the University of Pennsylvania, Vice President-Clinical Development at Amgen, Inc. in 2022, Senior VP-Clinical Development & Data Science at ChemoCentryx, Inc. from 2021 to 2022, Vice President-Clinical Development at Akebia Therapeutics, Inc. from 2016 to 2019, Vice President-Clinical Development at Exicure, Inc. from 2020 to 2021, and Senior Vice President-Medical Research at Tourmaline Bio, Inc. from 2023 to 2025.
Education includes a doctorate from Harvard Medical School and an undergraduate degree from Harvard College.
Aktive Positionen von Emil deGoma
| Unternehmen | Position | Beginn |
|---|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 27.07.2009 |
American College of Cardiology Foundation
 American College of Cardiology Foundation Medical/Nursing ServicesHealth Services Provides cardiovascular education services | Corporate Officer/Principal | 27.07.2009 |
American Heart Association, Inc.
 American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates a voluntary health organization | Corporate Officer/Principal | 27.07.2009 |
National Lipid Association
 National Lipid Association Miscellaneous Commercial ServicesCommercial Services Operates medical society focused on enhancing the practice of lipid management in clinical medicine | Corporate Officer/Principal | 27.07.2009 |
Ehemalige bekannte Positionen von Emil deGoma
| Unternehmen | Position | Ende |
|---|---|---|
| AMGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2022 |
| CHEMOCENTRYX, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2022 |
| EXICURE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2021 |
| AKEBIA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2019 |
Ausbildung von Emil deGoma
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
59
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Cortria Corp.
 Cortria Corp. Pharmaceuticals: MajorHealth Technology Develops drugs for cardiovascular disease | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates a voluntary health organization | Commercial Services |
American College of Cardiology Foundation
American College of Cardiology Foundation Medical/Nursing ServicesHealth Services Provides cardiovascular education services | Health Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Lipid Association
National Lipid Association Miscellaneous Commercial ServicesCommercial Services Operates medical society focused on enhancing the practice of lipid management in clinical medicine | Commercial Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exicure, Inc.
 Exicure, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops nucleic acid therapies against to neurological disorders and hair loss | Health Technology |
